Quest Diagnostics Incorporated
DGX · NYSE
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $16,745,460 | $15,442,560 | $18,147,040 | $21,626,250 |
| - Cash | $549,000 | $686,000 | $315,000 | $872,000 |
| + Debt | $7,087,000 | $5,498,000 | $4,714,000 | $4,773,000 |
| Enterprise Value | $23,283,460 | $20,254,560 | $22,546,040 | $25,527,250 |
| Revenue | $9,872,000 | $9,252,000 | $9,883,000 | $10,788,000 |
| % Growth | 6.7% | -6.4% | -8.4% | – |
| Gross Profit | $3,244,000 | $3,069,000 | $3,433,000 | $4,209,000 |
| % Margin | 32.9% | 33.2% | 34.7% | 39% |
| EBITDA | $1,894,000 | $1,732,000 | $1,820,000 | $3,159,000 |
| % Margin | 19.2% | 18.7% | 18.4% | 29.3% |
| Net Income | $871,000 | $854,000 | $946,000 | $1,995,000 |
| % Margin | 8.8% | 9.2% | 9.6% | 18.5% |
| EPS Diluted | 7.69 | 7.52 | 7.98 | 15.53 |
| % Growth | 2.3% | -5.8% | -48.6% | – |
| Operating Cash Flow | $1,334,000 | $1,272,000 | $1,718,000 | $2,233,000 |
| Capital Expenditures | -$425,000 | -$408,000 | -$404,000 | -$403,000 |
| Free Cash Flow | $909,000 | $864,000 | $1,314,000 | $1,830,000 |